Literature DB >> 11359747

Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease.

A Elhendy1, R T van Domburg, F B Sozzi, D Poldermans, J J Bax, J R Roelandt.   

Abstract

AIM: To compare the accuracy of exercise stress myocardial perfusion single photon emission computed tomography (SPECT) imaging for the diagnosis of coronary artery disease in patients with and without hypertension.
METHODS: A symptom limited bicycle exercise stress test in conjunction with 99m technetium sestamibi or tetrofosmin SPECT imaging was performed in 332 patients (mean (SD) age, 57 (10) years; 257 men, 75 women) without previous myocardial infarction who underwent coronary angiography. Of these, 137 (41%) had hypertension. Rest SPECT images were acquired 24 hours after the stress test. An abnormal scan was defined as one with reversible or fixed perfusion defects.
RESULTS: In hypertensive patients, myocardial perfusion abnormalities were detected in 79 of 102 patients with significant coronary artery disease and in nine of 35 patients without. In normotensive patients, myocardial perfusion abnormalities were detected in 104 of 138 patients with significant coronary artery disease and in 16 of 57 patients without. There were no differences between normotensive and hypertensive patients in sensitivity (77% (95% confidence interval (CI) 69% to 86%) v 75% (95% CI 68% to 83%)), specificity (74% (95% CI 60% to 89%) v 72% (95% CI 60% to 84%)), and accuracy (77% (95% CI 70% to 84%) v 74% (95% CI 68% to 80%)) of exercise SPECT for diagnosing coronary artery disease. The accuracy of SPECT was greater than electrocardiography, both in hypertensive patients (p = 0.005) and in normotensive patients (p = 0.0001). For the detection of coronary artery disease in individual vessels, sensitivity was 58% (95% CI 51% to 65%) v 57% (95% CI 51% to 64%), specificity was 86% (95% CI 82% to 90%) v 85% (95% CI 81% to 89%), and accuracy was 74% (95% CI 70% to 78%) v 74% (95% CI 70% to 78%) in patients with and without hypertension (NS).
CONCLUSIONS: In the usual clinical setting, the value of exercise myocardial perfusion scintigraphy for diagnosing coronary artery disease is not degraded by the presence of hypertension.

Entities:  

Mesh:

Year:  2001        PMID: 11359747      PMCID: PMC1729751          DOI: 10.1136/heart.85.6.655

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  34 in total

1.  Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal doppler echocardiography.

Authors:  M S Hamouda; H K Kassem; M Salama; M El Masry; N Shaaban; E Sadek; B K Khandheria; J B Seward; A Elhendy
Journal:  Am J Cardiol       Date:  2000-08-01       Impact factor: 2.778

2.  Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography.

Authors:  E G DePuey; E Guertler-Krawczynska; J V Perkins; W L Robbins; J D Whelchel; S D Clements
Journal:  Am J Cardiol       Date:  1988-08-01       Impact factor: 2.778

3.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

4.  Measurement of left ventricular wall thickness and mass by echocardiography.

Authors:  B L Troy; J Pombo; C E Rackley
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

5.  Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test.

Authors:  G Fragasso; C Lu; P Dabrowski; P Pagnotta; I Sheiban; S L Chierchia
Journal:  J Am Coll Cardiol       Date:  1999-08       Impact factor: 24.094

6.  Myocardial perfusion abnormalities in treated hypertensive patients without known coronary artery disease.

Authors:  A Elhendy; R T van Domburg; J J Bax; M M Ibrahim; J R Roelandt
Journal:  J Hypertens       Date:  1999-11       Impact factor: 4.844

7.  Assessment of cardiac status in hypertensive patients.

Authors:  R C Tarazi; F M Fouad
Journal:  J Hypertens Suppl       Date:  1985-11

8.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; D D Savage; R J Garrison; K M Anderson; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-04-15       Impact factor: 2.778

9.  Thallium-201 stress imaging in hypertensive patients.

Authors:  D S Schulman; C K Francis; H R Black; F J Wackers
Journal:  Hypertension       Date:  1987-07       Impact factor: 10.190

10.  Comparison of exercise perfusion and ventricular function imaging: an analysis of factors affecting the diagnostic accuracy of each technique.

Authors:  M D Osbakken; R D Okada; C A Boucher; H W Strauss; G M Pohost
Journal:  J Am Coll Cardiol       Date:  1984-02       Impact factor: 24.094

View more
  10 in total

Review 1.  The use of "overall accuracy" to evaluate the validity of screening or diagnostic tests.

Authors:  Anthony J Alberg; Ji Wan Park; Brant W Hager; Malcolm V Brock; Marie Diener-West
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

Review 2.  Clinical imaging for prevention: directed strategies for improved detection of presymptomatic patients with undetected atherosclerosis--Part I: Clinical imaging for prevention.

Authors:  Leslee J Shaw; Daniel S Berman; Roger S Blumenthal; Matthew J Budoff; Tracy L Faber; Tauqir Goraya; Sandra S Halliburton; Harvey Hecht; Hosen Kiat; Wolfgang Koenig; Shaista Malik; Michael Merhige; Khurram Nasir; James K Min; James O'Keefe; Donna M Polk; Paolo Raggi; Jeffrey A Rosenblatt; Ronald G Schwartz; Allen J Taylor; Gregory S Thomas; William Wijns
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

3.  Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis.

Authors:  Paola Gargiulo; Mario Petretta; Dario Bruzzese; Alberto Cuocolo; Maria Prastaro; Carmen D'Amore; Enrico Vassallo; Gianluigi Savarese; Caterina Marciano; Stefania Paolillo; Pasquale Perrone Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-04       Impact factor: 9.236

4.  Prognostic significance of ischemia location on stress myocardial perfusion SPECT: Tracing the fingerprints of the widow maker.

Authors:  Abdou Elhendy
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

5.  Myocardial perfusion imaging analysis in patients with regurgitant valvular heart disease.

Authors:  Manavjot Sidhu; Albert K Chan; Anand Chockalingam; Thomas Dresser
Journal:  J Nucl Cardiol       Date:  2011-02-08       Impact factor: 5.952

6.  High probability of disease in angina pectoris patients: is clinical estimation reliable?

Authors:  Poul F Høilund-Carlsen; Allan Johansen; Werner Vach; Henrik Wulff Christensen; Mette Møldrup; Torben Haghfelt
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

7.  Clinical utility of estimated glomerular filtration rate in patients undergoing gated SPECT.

Authors:  Michele Coceani; Alessia Gimelli; Clara Carpeggiani; Antonio L'abbate; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2009-01-22       Impact factor: 5.952

8.  Clinical management of coronary heart disease in hypertension : practical recommendations from the Italian Society of Hypertension (SIIA).

Authors:  Massimo Volpe; Bruno Trimarco; Allegra Battistoni; Giuseppe Mancia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-08-13

9.  Diagnostic value of SPECT, PET and PET/CT in the diagnosis of coronary artery disease: A systematic review.

Authors:  M Al Moudi; Z Sun; N Lenzo
Journal:  Biomed Imaging Interv J       Date:  2011-04-01

10.  A head-to-head comparison of the coronary calcium score by computed tomography with myocardial perfusion imaging in predicting coronary artery disease.

Authors:  Mansour Almoudi; Zhong-Hua Sun
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.